Key result
Flat troponin curves fail to rule out ACS in ~24% of patients, predicting low event-free survival.
Why the study?
Patients presenting with chest pain and elevated cTn but with a flat curve pose a diagnostic challenge, as guidelines consider this pattern unrelated to ACS.
What is the prognosis and rate of ACS in patients presenting with chest pain and a cardiac troponin flat curve based on their management?
Cohort (n=664)
What is the prognosis and rate of ACS in patients presenting with chest pain and a cardiac troponin flat curve based on their management?
Patients with chest pain and a cardiac troponin flat curve still have a 23.8% rate of ACS and face high mortality, challenging the notion that this pattern safely rules out ACS.
Answers are grounded in this paper and cite their sources.
Flat troponin curves may signal higher risk than guidelines assume; leaves open whether intensified evaluation improves outcomes.
Introduction Acute myocardial injury is defined by cardiac troponin (cTn) levels exceeding the 99th percentile upper reference limit, with dynamic rise/fall pattern (Δ), often suggesting acute coronary syndrome (ACS). However, some patients present with chest pain and elevated cTn but with a Δ<20% (flat curve): they are a diagnostic challenge because according to current guidelines this pattern is not related to an ACS. Aim of this study is to analyze the prognosis of these patients based on their management: admission or discharge from the emergengy department (ED) as well as the number of ACS finally found. Methods We prospectively analyzed data of 664 patients with suspected ACS and a cTn flat curve (Δ<20% in two high-sensitivity cTn-T determinations at 0/3 hours) from May 2023 to September 2025. A six-month follow-up was completed in 547 patients, with a median follow-up of 185 days. Prognosis was based on major cardiovascular events (MACE: mortality, infarction, revascularization, stroke, or vascular surgery) and non-cardiovascular events. Results in this group of patients mean age was 75.8±11.8 years, 62.8% males; 199 patients were admitted to Cardiology, 138 to other departments, and 327 were discharged directly from the ED. One hundred and fifty eight patients (23.8%) were finally diagnosed with ACS, (only 14.5% of them with non-invasive tests). Patients admitted to non-cardiology departments had more MACE, more mortality and more non-cardiovascular events. Global mortality was mostly due to non-cardiac causes and cardiac mortality was mainly due to heart failure in all three groups. These results are shown in Table 1. Kaplan-Meier curves (Figure 1) showed significant survival differences between admitted and discharged patients. Conclusions - Cardiac troponin flat curve is frequently found in patients with chest pain. Its presence does not rule out the ocurrence of an ACS. - In these patients, event-free survival was low, particularly in those admitted to non-cardiology departments, where mortality was high and mainly due to non-cardiovascular origin. Discharged patients were not event-free but had low cardiac mortality rates. - Patients with other conditions different than ACS and cTn flat curve must be consider as high risk patients, given the large number of events observed during follow-up.
No takes yet. Share an insight, caveat, or question.
Garcia et al. (2026) conducted a cohort in Suspected acute coronary syndrome with a cardiac troponin flat curve (n=664). Management strategy (admission to Cardiology, other departments, or discharge) was evaluated on Major cardiovascular events (MACE: mortality, infarction, revascularization, stroke, or vascular surgery) and non-cardiovascular events. A cardiac troponin flat curve in patients with suspected ACS did not rule out ACS (diagnosed in 23.8%), and was associated with low event-free survival, especially in non-cardiology admissions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: